Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

Authors

Makda S Gebre, Harvard University
Susanne Rauch, CureVac AG
Adrianus C M Boon, Washington University School of Medicine in St. Louis
et al

Journal

Nature

Publication Date

11-18-2021

Volume

601

Issue

7893

First Page

410

Last Page

414

Document Type

Open Access Publication

DOI

10.1038/s41586-021-04231-6

Rights and Permissions

Gebre, M.S., Rauch, S., Roth, N. et al. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine. Nature 601, 410–414 (2022). doi.org/10.1038/s41586-021-04231-6 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Gebre, Makda S; Rauch, Susanne; Boon, Adrianus C M; and et al, "Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine." Nature. 601, 7893. 410 - 414. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11674